Similar outcome of heart failure with reduced EF patients with and without atrial fibrillation: considerations from the ESC Heart Failure Long-Term Registry

  • Renato De Vecchis | devecchis.erre@virgilio.it Preventive Cardiology and Rehabilitation Unit, “S. Gennaro dei Poveri” Hospital, Naples, Italy.

Abstract

Recently, transcatheter ablation of atrial fibrillation (AF) has been validated by international societal guidelines as a technique suitable for both treatment and secondary prevention of paroxysmal, persistent or long-lasting persistent AF in highly symptomatic patients in whom at least one antiarrhythmic drug had been tested.

Downloads

Download data is not yet available.

PUBLICATION METRICS

PlumX Metrics provide insights into the ways people interact with individual pieces of research output (articles, conference proceedings, book chapters, and many more) in the online environment. Examples include, when research is mentioned in the news or is tweeted about. Collectively known as PlumX Metrics, these metrics are divided into five categories to help make sense of the huge amounts of data involved and to enable analysis by comparing like with like.

Published
2019-09-10
Info
Issue
Section
Letters to the Editor
Keywords:
Atrial fibrillation, ejection fraction, AF ablation
Statistics
  • Abstract views: 545

  • PDF: 324
How to Cite
De Vecchis, R. (2019). Similar outcome of heart failure with reduced EF patients with and without atrial fibrillation: considerations from the ESC Heart Failure Long-Term Registry. Monaldi Archives for Chest Disease, 89(3). https://doi.org/10.4081/monaldi.2019.1061